These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35241544)

  • 1. The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma.
    Kinoshita A; Hagiwara N; Osawa A; Akasu T; Matsumoto Y; Ueda K; Saeki C; Oikawa T; Koike K; Saruta M
    In Vivo; 2022; 36(2):865-873. PubMed ID: 35241544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis.
    Kanno H; Goto Y; Sasaki S; Fukutomi S; Hisaka T; Fujita F; Akagi Y; Okuda K
    Sci Rep; 2021 Apr; 11(1):9038. PubMed ID: 33907232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric nutritional risk index predicts prognosis after hepatectomy in elderly patients with hepatitis B virus-related hepatocellular carcinoma.
    Li L; Wang H; Yang J; Jiang L; Yang J; Wu H; Wen T; Yan L
    Sci Rep; 2018 Aug; 8(1):12561. PubMed ID: 30135506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
    Hiraoka A; Kumada T; Tada T; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Toyoda H; Ohama H; Tsutsui A; Itokawa N; Hayama K; Arai T; Imai M; Nakamura S; Michitaka K; Hiasa Y; Kudo M;
    Oncology; 2020; 98(5):295-302. PubMed ID: 32097925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geriatric Nutritional Risk Index and the Survival of Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Xu X; Kang F; Zhang N; Niu Y; Jia J
    Horm Metab Res; 2023 Oct; 55(10):692-700. PubMed ID: 37385295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of circulating IgM and geriatric nutritional risk index predicts the prognostic of hepatocellular carcinoma patients who underwent immune checkpoint inhibitors.
    Liu C; Zhao H; Wang P; Guo Z; Qu Z
    Int Immunopharmacol; 2023 Oct; 123():110704. PubMed ID: 37506504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Geriatric Nutritional Risk Index After Initial Hepatectomy for Hepatocellular Carcinoma: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
    Imaoka Y; Ohira M; Kobayashi T; Honmyo N; Hamaoka M; Onoe T; Abe T; Oishi K; Inoue M; Ohdan H;
    J Gastrointest Surg; 2023 Jun; 27(6):1152-1158. PubMed ID: 36869207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.
    Koizumi Y; Hirooka M; Hiraoka A; Ochi H; Tanaka T; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Miyake T; Matsuura B; Michitaka K; Joko K; Abe M; Hiasa Y
    Endocr J; 2019 Sep; 66(9):787-792. PubMed ID: 31142692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma.
    Yang CK; Huang KT; Qin W; Wu QY; Huang XL; Peng K; Lao Q; Ye XP; Zhu GZ; Li TM; Peng T
    Clin Nutr ESPEN; 2024 Feb; 59():355-364. PubMed ID: 38220397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma.
    Tsukagoshi M; Araki K; Igarashi T; Ishii N; Kawai S; Hagiwara K; Hoshino K; Seki T; Okuyama T; Fukushima R; Harimoto N; Shirabe K
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor tolerability of lenvatinib in elderly patients ≥80 years old with hepatocellular carcinoma: A multicenter observational study.
    Kinoshita A; Hagiwara N; Osawa A; Akasu T; Matsumoto Y; Ueda K; Saeki C; Oikawa T; Koike K; Saruta M
    J Oncol Pharm Pract; 2023 Apr; 29(3):626-636. PubMed ID: 35112972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma.
    Kim S; Kim KH; Kim BK; Park JY; Ahn SH; Kim DY; Kim SU
    J Gastroenterol Hepatol; 2021 May; 36(5):1317-1325. PubMed ID: 33217054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study.
    Yamana I; Takeno S; Shimaoka H; Yamashita K; Yamada T; Shiwaku H; Hashimoto T; Yamashita Y; Hasegawa S
    Int J Surg; 2018 Aug; 56():44-48. PubMed ID: 29602015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.
    Sun X; Zhang Q; Mei J; Yang Z; Chen M; Liang T
    BMC Cancer; 2022 Mar; 22(1):293. PubMed ID: 35305593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma.
    Enomoto D; Yamamoto K; Matsumoto Y; Morioka A; Omura T; Komatsu S; Yano Y; Fukumoto T; Yano I
    Anticancer Res; 2023 Mar; 43(3):1317-1323. PubMed ID: 36854508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study.
    Shimose S; Kawaguchi T; Iwamoto H; Tanaka M; Miyazaki K; Ono M; Niizeki T; Shirono T; Okamura S; Nakano M; Suga H; Yamaguchi T; Yokokura Y; Noguchi K; Koga H; Torimura T
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32295043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess.
    Xu J; Zhou X; Zheng C
    BMC Geriatr; 2019 Jan; 19(1):14. PubMed ID: 30651062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
    Etani T; Naiki T; Sugiyama Y; Nagai T; Iida K; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Okada T; Banno R; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
    Oncology; 2020; 98(12):876-883. PubMed ID: 32862183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preoperative geriatric nutritional risk index predicts long-term prognosis in elderly locally advanced rectal cancer patients: a two-center retrospective cohort study.
    Lu S; Li X; Li X; Zhang Q; Wang Y; Peng R; Fu W; Wang H
    Aging Clin Exp Res; 2023 Feb; 35(2):311-321. PubMed ID: 36399323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
    Tada T; Kumada T; Hiraoka A; Michitaka K; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Yasuda S; Toyoda H; Fukunishi S; Ohama H; Kawata K; Nakamura S; Nouso K; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Joko K; Koizumi Y; Hiasa Y;
    Oncology; 2021; 99(8):518-527. PubMed ID: 33906189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.